BIONEUTRAL

BIO Return on Equity (ROE) Analysis

3.1%

Higher than 29% of Healthcare sector peers

Updated 413h ago·SEC filings & market data

Key Takeaway

Return on equity (ROE) measures how much profit a company generates for every dollar of shareholder equity, so Bio-Rad's 3.1% means it earns $0.031 per $1 of equity.

Sector Performance

29th percentile

BIO

3.1%

Sector Median

11.3%

Sector Avg

72.2%

Prior Period

2.5%(Jul 2026)

↑ Improving

📊

Deep Analysis

Return on equity (ROE) measures how much profit a company generates for every dollar of shareholder equity, so Bio-Rad's 3.1% means it earns $0.031 per $1 of equity.

That is below the healthcare sector median of 9.6%, placing the company at the 37th percentile among peers, meaning roughly two-thirds of sector companies have higher ROE. The year-over-year change is not available, but quarter-over-quarter ROE rose by 24.0%, from 2.5% to 3.1% most recently. The combination of a low absolute ROE with a sharp quarterly improvement suggests the company is still underperforming its sector on profitability, yet the upward move could signal early recovery. For investors, this level implies higher risk than the peer group, though the positive QoQ change offers a chance for improving returns if the trend continues. This metric contradicts a fully bearish stance but does not confirm strong performance; it directly supports the overall NEUTRAL verdict by showing weak profitability alongside recent momentum.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about BIO?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does BIO's Return on Equity (ROE) compare to its sector?

BIO's Return on Equity (ROE) of 3.1% compares to a Healthcare sector median of 11.3%, placing it in the 29th percentile.

Who are BIO's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: ABT (12.5%), ALGN (10.1%), TMO (13.5%), TECH (9.0%), VEEV (13.9%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.